CUSIP: 85789A105
Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
893,103
-
Share change
-
-424,484
-
Total reported value
-
$276,000
-
Price per share
-
$0.31
-
Number of holders
-
10
-
Value change
-
-$106,659
-
Number of buys
-
3
-
Number of sells
-
11
Quarterly Holders Quick Answers
What is CUSIP 85789A105?
CUSIP 85789A105 identifies MITO - STEALTH BIOTHERAPEUTICS CORP - SPONSORED ADS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2022
-
Previous quarter:
Q2 2022
Recent filing periods for CUSIP 85789A105:
Institutional Holders of STEALTH BIOTHERAPEUTICS CORP - SPONSORED ADS (MITO) as of Q3 2022
As of 30 Sep 2022,
STEALTH BIOTHERAPEUTICS CORP - SPONSORED ADS (MITO) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
893,103 shares.
The largest 10 holders included
Ikarian Capital, LLC, BROWN BROTHERS HARRIMAN & CO, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, ENVESTNET ASSET MANAGEMENT INC, CAPTRUST FINANCIAL ADVISORS, TWO SIGMA ADVISERS, LP, and ADVISOR GROUP HOLDINGS, INC..
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.